InvestorsHub Logo

moxa1

04/18/17 9:47 PM

#85587 RE: FORU #85576

I hope you're right but the safety study is what we're waiting on as the efficacy portion of the pre clinical trial is already complete with a reported 70% effectiveness rate at reducing inflammatory markers relating to psoriasis. According to the last 8K we started the IRB safety study in April (this month). I don't know how long this will take but I'd be surprised if we hear of the results before the end of the month. My guess would be sometime in May. Remember Dr. Baruch said they will publish the results and I believe he said by the end of May but I may be mistaken. Perhaps if you can confirm your information that would be helpful. It takes time to write up the results and then get them published. They also have to secure their IP Bio Data if I remember correctly and that can add time as well.